Teens with heart disease improve exercise capacity in large clinical trial

(Children's Hospital of Philadelphia) The largest-ever clinical trial of a medication for pediatric cardiology patients found that an oral drug significantly improved exercise capacity in adolescent patients with severe, congenital single-ventricle heart defects. A study leader says the physiologic benefits represent a milestone in the care of those who have undergone the Fontan procedure, a palliative operation for single-ventricle disease.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news